Sonnet BioTherapeutics completes $2 million convertible note and warrant sale By Investing.com
Sonnet BioTherapeutics completes $2 million convertible note and warrant sale…
0,560$
-58,54%
Echtzeit-Aktienkurs Biora Therapeutics
Bid:
Ask:
Nachrichten zur Biora Therapeutics Aktie
Bicara Therapeutics: A Decline Off The IPO Spells Wait For Me
…
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic…
Bicara Therapeutics prices upsized $315M offering
…
Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to…
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
SAN DIEGO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic…
Biora Therapeutics, Inc. (BIOR) Q2 2024 Earnings Call Transcript
…
Bicara Therapeutics Picks Morgan Stanley For IPO of Up to $150 Million
Bicara Therapeutics is working with Morgan Stanley on a US initial public offering, people familiar with the situation said, as…
Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms By Investing.com
Earnings call: Biora Therapeutics reports progress on NaviCap and BioJet platforms…
Biora Therapeutics, Inc. (BIOR) Q1 2024 Earnings Call Transcript
…
Biora Therapeutics, Inc. (BIOR) Q4 2023 Earnings Call Transcript
…